NFKB1 and endothelial dysfunction: This release is driven by the degradation of IκB, leading to the nuclear translocation of NF‐κB where it activates target genes.[6] Identifying these triggers and understanding the molecular mechanisms governing NF‐κB activation are crucial for developing strategies to restrain NF‐κB activity and prevent the onset of endothelial dysfunction.